Vicki specialises in the strategy and implementation of HEOR solutions. With extensive experience in developing HTA dossiers, systematic literature reviews, and economic models, she has contributed to over 19 HTA submissions across NICE, SMC, and NCPE. Vicki has also represented companies at HTA meetings, leading the development of tools that support both payer and internal needs. Her work in statistical analysis, including Bayesian methods and network meta-regressions, has been widely used in healthcare decision-making.
Vicki holds a Master's in Economic Evaluation in Health Care (Distinction) from City University of London and a Master's in Mathematics from the University of Bath.
Led eight appraisals and contributed to 11 more, across key submissions in oncology and rare diseases.
Expert in Bayesian statistical methods
Developed sophisticated statistical models, including Bayesian NMAs and network meta-regressions.
Development of key payer tools
Led the development of budget impact models and payer-facing value propositions.
Experience in range of therapy areas:
Epilepsy
Thrombosis
Hepatology
Rheumatoid arthritis
Oncology
Infectious diseases
Alopecia areata
Peanut allergy, rare diseases
FIECON exceeds my expectations by genuinely trying to achieve the best outcomes for our company. Their flexibility to adapt to unexpected changes and apply technical rigour, while respecting the commercial focus of the company is unparalleled. We see FIECON as part of our extended team.”
Senior Market Access Manager, Mid-sized Pharma
It was brilliantly smart and very well explained. It seems obvious now but that is what genius is, making complex things appear simple.”
Associate Director, Mid-sized Pharma
FIECON are my go to trusted partner. The team deliver high-quality work to timeline, every time. But more than this, FIECON has worked as part of our team, working towards achieving the best possible outcome by providing high level strategic input and challenge during our discussions.”
Market Access Director, Small Biotech
FIECON’s highly skilled expert team helped us to successfully tackle a number of tough pricing and access challenges. Apart from their flawless technical expertise, we have a reliable thought partner to pressure test new ideas and strategies that have a broader relevance than purely health economic aspects.”
Disease Area Director, Big Pharma
The pricing and market access research was a high quality work project, which included detailed information to define the overall and country strategy while the gap analysis was instrumental in the next steps preparation. ”
Executive Director, Biotech
FIECON’s strategic approach to problem solving is a breath of fresh air. We highly value their HTA knowledge and expertise, and they consistently deliver the best solution for us.”
Value Demonstration & Access Lead, Big Pharma
It is a pleasure to work with FIECON. The team are passionate about what they do and it really shows in their high-quality, creative solutions. Working with FIECON gives your projects the highest chance of success.”
Senior Vice President, Small Biotech
FIECON’s team is highly experienced, commercially focused, responsive and flexible. A particular strength I highlight is that FIECON’s team becomes a true partner with all company functions that they interact with. ”
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts. More info
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts.
